Boai NKY Medical Holdings Ltd. (SHE:300109)
China · Delayed Price · Currency is CNY 13.96
-0.04 (-0.29%)
Sep 4, 2026, 3:04 PM CST
Boai NKY Medical Holdings Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 3, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
| 8,053 | 8,161 | 7,731 | 5,551 | 7,478 | 7,491 | |
Market Cap Growth | -13.17% | 5.56% | 39.28% | -25.77% | -0.18% | 69.25% |
Enterprise Value | 8,029 | 7,799 | 7,794 | 5,257 | 6,843 | 7,886 |
Last Close Price | 13.96 | 13.84 | 12.95 | 9.29 | 12.23 | 10.63 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 3, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
PE Ratio | 54.36 | 42.93 | 22.11 | 11.26 | 25.66 | 36.18 |
Forward PE | - | 56.78 | 56.78 | 56.78 | 56.78 | 56.78 |
PS Ratio | 6.64 | 6.93 | 4.81 | 3.51 | 5.03 | 6.14 |
PB Ratio | 2.43 | 2.23 | 2.14 | 1.58 | 2.40 | 2.26 |
P/TBV Ratio | 2.76 | 2.51 | 2.41 | 1.81 | 2.79 | 2.61 |
P/FCF Ratio | 43.08 | 69.34 | - | 50.29 | - | - |
P/OCF Ratio | 22.12 | 24.14 | 30.20 | 11.37 | 29.70 | 172.44 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 3, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
EV/Sales Ratio | 6.62 | 6.62 | 4.85 | 3.32 | 4.61 | 6.46 |
EV/EBITDA Ratio | 22.83 | 20.91 | 14.57 | 8.14 | 15.43 | 38.09 |
EV/EBIT Ratio | 31.09 | 28.75 | 18.01 | 9.20 | 17.94 | 58.34 |
EV/FCF Ratio | 42.96 | 66.27 | - | 47.63 | - | - |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 3, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Debt / Equity Ratio | 0.17 | 0.09 | 0.13 | 0.02 | 0.02 | 0.03 |
Debt / EBITDA Ratio | 1.57 | 0.88 | 0.84 | 0.09 | 0.16 | 0.48 |
Debt / FCF Ratio | 2.96 | 2.81 | - | 0.55 | - | - |
Net Debt / Equity Ratio | 0.00 | -0.10 | -0.04 | -0.07 | -0.16 | -0.38 |
Net Debt / EBITDA Ratio | 0.02 | -1.03 | -0.24 | -0.41 | -1.14 | -6.11 |
Net Debt / FCF Ratio | 0.03 | -3.27 | 6.80 | -2.40 | 35.43 | 6.84 |
Asset Turnover | 0.27 | 0.27 | 0.38 | 0.41 | 0.39 | 0.30 |
Inventory Turnover | 2.01 | 1.84 | 2.49 | 2.48 | 3.33 | 3.52 |
Quick Ratio | 1.32 | 2.23 | 1.45 | 1.86 | 2.21 | 3.77 |
Current Ratio | 1.81 | 2.95 | 2.14 | 2.78 | 2.86 | 4.39 |
Return on Equity (ROE) | 4.24% | 5.12% | 9.68% | 14.64% | 8.75% | 6.10% |
Return on Assets (ROA) | 3.60% | 3.88% | 6.45% | 9.23% | 6.28% | 2.11% |
Return on Invested Capital (ROIC) | 6.26% | 6.31% | 11.05% | 16.16% | 11.85% | 3.30% |
Return on Capital Employed (ROCE) | 7.30% | 7.00% | 11.80% | 15.90% | 11.90% | 4.00% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 3, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Earnings Yield | 1.89% | 2.33% | 4.52% | 8.88% | 3.90% | 2.76% |
FCF Yield | 2.32% | 1.44% | -0.24% | 1.99% | -0.19% | -2.47% |
Dividend Yield | 1.19% | 1.20% | 1.60% | 5.98% | 2.27% | 2.61% |
Payout Ratio | 146.57% | 68.03% | 94.02% | 33.32% | 58.32% | 20.04% |
Buyback Yield / Dilution | -1.81% | -0.36% | -0.48% | 6.03% | -2.67% | -4.93% |
Total Shareholder Return | -0.61% | 0.85% | 1.13% | 12.01% | -0.40% | -2.31% |